Squarepoint’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $158K | Buy |
59,095
+44,508
| +305% | +$119K | ﹤0.01% | 2394 |
|
|
2025
Q1 | $117K | Sell |
14,587
-106
| -0.7% | -$851 | ﹤0.01% | 2494 |
|
|
2024
Q4 | $142K | Buy |
+14,693
| New | +$142K | ﹤0.01% | 2463 |
|
|
2024
Q1 | – | Sell |
-12,397
| Closed | -$194K | – | 3030 |
|
|
2023
Q4 | $194K | Buy |
12,397
+9,682
| +357% | +$151K | ﹤0.01% | 2143 |
|
|
2023
Q3 | $134K | Sell |
2,715
-1,437
| -35% | -$71.1K | ﹤0.01% | 2209 |
|
|
2023
Q2 | $325K | Buy |
4,152
+954
| +30% | +$74.6K | ﹤0.01% | 1832 |
|
|
2023
Q1 | $290K | Buy |
3,198
+38
| +1% | +$3.44K | ﹤0.01% | 1695 |
|
|
2022
Q4 | $373K | Buy |
+3,160
| New | +$373K | ﹤0.01% | 1599 |
|
|
2022
Q3 | – | Sell |
-738
| Closed | -$66K | – | 2614 |
|
|
2022
Q2 | $66K | Sell |
738
-489
| -40% | -$43.7K | ﹤0.01% | 1932 |
|
|
2022
Q1 | $190K | Buy |
1,227
+562
| +85% | +$87K | ﹤0.01% | 1920 |
|
|
2021
Q4 | $198K | Buy |
+665
| New | +$198K | ﹤0.01% | 2097 |
|
|
2021
Q3 | – | Sell |
-950
| Closed | -$431K | – | 2839 |
|
|
2021
Q2 | $431K | Buy |
+950
| New | +$431K | ﹤0.01% | 1714 |
|